Please wait a minute...
文章检索
预防医学  2024, Vol. 36 Issue (6): 523-526    DOI: 10.19485/j.cnki.issn2096-5087.2024.06.015
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
海珠区14岁以下儿童水痘突破病例特征分析
王颖, 江媚, 华丽, 林玉幸
广州市海珠区疾病预防控制中心免疫规划科,广东 广州 510288
Characteristics of varicella breakthrough cases aged under 14 years in Haizhu District
WANG Ying, JIANG Mei, HUA Li, LIN Yuxing
Department of Immune Planning, Haizhu District Center for Disease Control and Prevention, Guangzhou, Guangdong 510288, China
全文: PDF(856 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解广州市海珠区<14岁水痘突破病例特征及疫苗接种对突破病例发生的影响,为完善水痘疫苗免疫策略提供依据。方法 通过中国疾病预防控制信息系统和广东省预防接种与疫苗流通管理信息系统分别收集2015—2022年海珠区<14岁水痘病例资料和疫苗接种资料,描述性分析水痘突破病例的发病时间、人群分布特征和疫苗接种情况,采用最小二乘法拟合二元三次函数分析初免月龄、接种间隔对突破间隔的影响。结果 2015—2022年海珠区报告<14岁水痘突破病例4 008例,占水痘病例总数的29.16%。以1剂突破病例为主,3 607例占90.00%。1剂突破病例占病例总数的比例呈下降趋势,2剂突破病例的比例呈上升趋势(均P<0.05)。突破病例发病高峰在3—5月和11月至次年1月,男女比为1.41∶1,发病年龄主要在4~6岁,1 189例占29.67%。初免月龄集中在12~<24月龄,2 662例占66.42%;2剂接种多在48~<60月龄完成,136例占33.92%。初免在12~<36月龄、接种间隔45个月内的病例突破间隔较长,MQR)为25.24(20.00)月。初免月龄、接种间隔与突破间隔呈负相关(P<0.05)。结论 2015—2022年海珠区<14岁水痘突破病例集中在开学季,高发于学龄前儿童。建议儿童在36月龄内完成第1剂水痘疫苗接种,并在间隔45个月内完成第2剂加强免疫。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
王颖
江媚
华丽
林玉幸
关键词 水痘突破病例水痘疫苗加强免疫    
AbstractObjective To learn the characteristics of varicella breakthrough cases aged under 14 years in Haizhu District, Guangzhou City and the effects of vaccination on incidence of breakthrough cases, so as to provide the basis for improving varicella vaccination strategy. Methods Data of varicella cases aged under 14 years and vaccination in Haizhu District were collected through Chinese Disease Prevention and Control Information System and Guangdong Provincial Vaccination and Vaccine Circulation Management Information System from 2015 to 2022. Temporal distribution, population distribution and vaccination history of varicella breakthrough cases were descriptively analyzed. Effects of primary immunization age and inoculation interval on breakthrough interval were analyzed using least square method fitting bi-cubic functional equation. Results A total of 4 008 varicella breakthrough cases aged under 14 years were reported in Haizhu District from 2015 to 2022, accounting for 29.16% of all varicella cases. There were mainly 1-dose breakthrough cases, with 3 607 cases accounting for 90.00%. The proportion of 1-dose breakthrough cases showed a downward trend, while the proportion of 2-dose breakthrough cases showed an upward trend (both P<0.05). The epidemics peaked from March to May and from November to January, with a male-to-female ratio of 1.41︰1. The age of onset was mainly at 4 to 6 years, with 1 189 cases accounting for 29.67%. The primary immunization age was mainly ranged from 12 to <24 months, with 2 662 cases accounting for 66.42%. Vaccination of the second dose was concentrated at the age of 48 to <60 months, with 136 cases accounting for 33.92%. The breakthrough interval was relatively long among cases with primary immunization age at 12 to <36 months and inoculation interval within 45 months, with a median breakthrough interval of 25.24 (interquartile range, 20.00) months. Primary immunization age and inoculation interval were negatively correlated with breakthrough interval (P<0.05). Conclusions The varicella breakthrough cases aged under 14 years in Haizhu District from 2015 to 2022 were mainly occurred at the beginning of the new term, with a high incidence among preschool children. It is recommended that children receive the first dose of varicella vaccine within 36 months of age and booster within 45 months of interval.
Key wordsvaricella    breakthrough case    varicella vaccine    booster immunity
收稿日期: 2024-02-05      修回日期: 2024-05-04      出版日期: 2024-06-10
中图分类号:  R511.5  
基金资助:广州市卫生健康科技项目(20231A010074); 海珠区科技计划项目(海科工商信计2022-26)
作者简介: 王颖,硕士,主管医师,主要从事传染病防制工作,E-mail:422921488@qq.com
引用本文:   
王颖, 江媚, 华丽, 林玉幸. 海珠区14岁以下儿童水痘突破病例特征分析[J]. 预防医学, 2024, 36(6): 523-526.
WANG Ying, JIANG Mei, HUA Li, LIN Yuxing. Characteristics of varicella breakthrough cases aged under 14 years in Haizhu District. Preventive Medicine, 2024, 36(6): 523-526.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2024.06.015      或      http://www.zjyfyxzz.com/CN/Y2024/V36/I6/523
[1] HALES C M,HARPAZ R,ORTEGA-SANCHEZ I,et al.Update on recommendations for use of herpes zoster vaccine[J].MMWR,2014,63(33):729-731.
[2] 许小康,孟祥梅,王瑶,等.六安市某小学水痘暴发疫情突破病例分析[J].预防医学,2020,32(3):289-291.
[3] 王翠玲,吕海英,李雷,等.水痘疫苗在学校水痘暴发疫情中保护效果的病例对照研究[J].现代预防医学,2022,49(23):4390-4393.
[4] SUO L D,LU L,ZHAO D,et al.Impact of a 2-dose voluntary vaccination strategy on varicella epidemiology in Beijing,2011-2017[J].Vaccine,2020,38(20):3690-3696.
[5] 黄恩妙,王翠玲,吕海英.中山市1起小学水痘暴发疫情调查[J].预防医学,2021,33(4):391-394.
[6] 蒋静凤,王旭雯.无锡2017—2018年儿童水痘疫情中突破性病例分析[J].中国学校卫生,2020,41(8):1253-1255.
[7] 师燕,朱一凡,王静,等.长垣市儿童接种不同剂次水痘疫苗免疫史突破病例分析[J].黑龙江医学,2022,46(17):2104-2106.
[8] 杨静静,吴向青,申井强.2019年苏州市相城区水痘暴发疫情及突破性病例流行病学特征分析[J].江苏预防医学,2021,32(5):616-617,619.
[9] 卢肇骏,沈鹏,孙烨祥,等.鄞州区2009—2018年出生儿童水痘疫苗接种保护效果分析[J].预防医学,2021,33(8):804-807.
[10] 广东省卫生计生委办公室.广东省卫生计生委办公室关于印发广东省儿童水痘疫苗预防接种方案(2017年版)的通知:粤卫办〔2017〕57号[EB/OL].[2024-05-04].https://wsjkw.gd.gov.cn/zwgk_zwwgk/content/post_2497718.html.
[11] 李懿涵. 广东省不同水痘疫苗免疫策略保护作用评估[D].广州:南方医科大学,2023.
[12] 刘梅芳,刘爱忠.2017—2021年株洲市天元区10岁以下儿童水痘流行状况及疫苗接种情况分析[J].职业卫生与病伤,2022,37(6):332-336.
[13] 高舒,刘海波,吴涛,等.2013—2019年北京市房山区水痘流行病学特征分析[J].预防医学情报杂志,2021,37(6):782-787.
[14] 汤玲,修仕信,顾敏华,等.2013—2017年江苏省江阴市14岁以下儿童水痘流行特征分析[J].医学动物防制,2020,36(4):364-367.
[15] 沈艳,邱海岩,邵海枫,等.2016—2017年张家港市水痘突发公共卫生事件流行病学特征分析[J].现代预防医学,2019,46(14):2518-2521.
[16] 李保军,施方伦,林伊荷,等.海曙区水痘突破病例特征分析[J].预防医学,2024,36(1):55-57.
[17] 张巧英,陈雷,陆元英,等.2017—2022年上海市松江区水痘流行特征及空间聚集性分析[J].华南预防医学,2023,49(10):1335-1338,1342.
[18] 陈金生,赖倩盈,梁文佳,等.一起小学水痘暴发疫情的疫苗保护效果研究[J].华南预防医学,2018,44(4):352-354.
[19] 殷大鹏,卢莉,刘燕敏.水痘疫苗预防接种专家共识[J].首都公共卫生,2023,17(5):257-266.
[1] 朱澜澜, 张钟, 卞增惠, 许阳婷, 孙红敏, 刘婷. 2017—2022年南京市水痘突发公共卫生事件的空间聚集特征分析[J]. 预防医学, 2024, 36(3): 215-218.
[2] 李保军, 施方伦, 林伊荷, 童思未, 刘芳. 海曙区水痘突破病例特征分析[J]. 预防医学, 2024, 36(1): 55-57.
[3] 王瑶, 潘璠, 张欢, 陈亚飞, 秦伟. 气温对六安市水痘发病风险的影响研究[J]. 预防医学, 2023, 35(8): 692-696.
[4] 何飞, 马永法, 顾春艳, 潘铭, 陈万庚. 2005—2021年盐都区水痘流行特征[J]. 预防医学, 2023, 35(1): 61-64.
[5] 陈蓓蕾, 王瑶, 陈智超, 潘璠, 解少煜, 秦伟. 六安市1~12岁儿童水痘-带状疱疹病毒抗体水平调查[J]. 预防医学, 2022, 34(5): 503-506.
[6] 高波, 薛琦臻, 张俊锋, 潘冉冉, 孙烨祥. 2010—2020年鄞州区水痘流行特征分析[J]. 预防医学, 2021, 33(9): 913-915.
[7] 卢肇骏, 沈鹏, 孙烨祥, 潘兴强, 杨颖, 王炜豪, 郑卫军. 鄞州区2009—2018年出生儿童水痘疫苗接种保护效果分析[J]. 预防医学, 2021, 33(8): 804-807.
[8] 沈建勇, 张超, 罗小福, 徐秦儿, 陈奕晔. 湖州市1~12岁儿童水痘疫苗接种情况调查[J]. 预防医学, 2021, 33(6): 624-626.
[9] 黄恩妙, 王翠玲, 吕海英. 中山市1起小学水痘暴发疫情调查[J]. 预防医学, 2021, 33(4): 391-394.
[10] 许玉洋, 刘艳, 张小平, 杜渐, 车鑫仁, 王骏, 顾雯雯, 张学潮, 江伟. 杭州市2~11岁儿童水痘减毒活疫苗接种情况调查[J]. 预防医学, 2020, 32(7): 689-691.
[11] 陈颖萍, 邓璇, 何寒青, 王慎玉, 梁贞贞, 胡晓松, 邢博, 吕华坤. 浙江省水痘暴发疫情流行特征分析[J]. 预防医学, 2020, 32(4): 366-369.
[12] 许小康, 孟祥梅, 王瑶, 解少煜, 龚鹏飞, 夏峰, 秦伟. 六安市某小学水痘暴发疫情突破病例分析[J]. 预防医学, 2020, 32(3): 289-291.
[13] 朱珠英, 周珊慧. 龙湾区健康人群水痘-带状疱疹病毒抗体水平调查[J]. 预防医学, 2020, 32(11): 1144-1146.
[14] 魏晶娇, 倪朝荣, 邵永强, 李万仓, 王志刚, 孙肖瑜, 刘可欣, 杨海燕. 2010—2018年温州市水痘流行特征分析[J]. 预防医学, 2020, 32(11): 1141-1143.
[15] 蒋薇薇,范引光,靳玉慧,崔光辉,祖萍,赵秀玲,毕方龙,田余红. 蜀山区水痘流行特征分析[J]. 预防医学, 2018, 30(9): 917-920.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed